Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.

What Do Studies Say?

The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.

The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.

The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.

The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

How Was The Study Conducted?

The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.

Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Why Does It Work So Well Against Alcoholism?

The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.

However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.

The number of children who have died from a mysterious illness in the northern state of Rajasthan has risen to 13, as health officials continue efforts to determine the cause.

According to media reports, a six-year-old girl from Bhugabhatt village of Gram Panchayat Bharkundi was the latest victim on Sunday (April 12) morning. There was another death from this mysterious illness on Saturday, Udaipur Times reported.

So far, seven children have reportedly died from the Lasadiya of Salumbar district six succumbed from Parsola village in the state's Pratapgarh district.

Notably, two children died in Dholi Magri and two in Mahudi Kheda, as per administrators Narayanlal Meena of Ambav and Shankarlal Meena of Lohagarh from the Dhariyawad subdivision of Pratapgarh district. However, the authorities are yet to find a link between the two.

All children reportedly experienced a sudden onset of fever that worsened rapidly, and claimed the lives of children within 24 hours.

The Health officials noted that at least 85 children were hospitalized with similar symptoms.

Speaking to the media, Salumber’s district collector, Muhammed Junaid, said that two teams from the health department have been monitoring the situation constantly for the last few days.

“They have collected blood, stool, and saliva samples from children with suspected symptoms. Their samples have been sent to the National Institute of Virology (NIV) in Pune. We suspect it could be a kind of viral encephalitis, but we are yet to get the test report from NIV,” Junaid said

The Health Department has also started a door-to-door survey in the sub-division.

Junaid noted that the survey was conducted across 120,961 houses in the Udaipur division, during which over 940 children were found with similar symptoms.

The local MLA has written a letter to Chief Minister Bhajan Lal Sharma demanding an investigation into the matter.

Earlier, mosquito-borne viral encephalitis (brain infection) or a Chandipura virus variant was suspected to be the reason behind the illness and deaths. However, lab confirmation is still pending. Samples have been collected and sent for testing.

"Anti-larval activity has also been carried out in 5,532 places after medical teams suspected viral encephalitis,” Junaid said.

What Is Encephalitis?

Encephalitis is the inflammation of the brain, caused by viral or bacterial infections, or by immune cells mistakenly attacking the brain.

People with encephalitis often show mild flu-like symptoms such as

• fever,
• fatigue,
• headache,
• body aches,
• confusion,
• seizures,
• changes in behavior or personality.

What Is The Chandipura Virus Disease?

Chandipura virus is a type of arbovirus that is a member of the vesicular virus genus of the Rhabdoviridae family. It is transmitted primarily through phlebotomine sandflies and sometimes through ticks and mosquitoes.

First identified in India in 1965, the virus is named after the Chandipura village in Maharashtra where it was initially isolated.

Its symptoms include:

• sudden onset of high-grade fever,
• diarrhea,
• vomiting,
• seizures,
• altered sensorium which can ultimately lead to death within 24 to 72 hours.

How To Prevent?

The risk of getting encephalitis can be reduced by protecting oneself from mosquito bites and staying up-to-date with vaccinations.

One must ensure getting vaccinated against mumps, chickenpox, measles, and rubella.

Vector control measures such as the use of insecticides, bed nets, wearing full-sleeved clothes, and improving sanitation can also help prevent the disease.

Some feel anxious because of work pressure, but there are others who feel agitated and stressed when they are not engaged. Legendary Bollywood actor Amitabh Bachchan falls into the latter group. The 83-year-old has never really retired and has continued to entertain his fans and rule their hearts through his work. Over the years, there have been several interviews about his routine, discipline, and how the actor likes to stay busy. In a recent blog, he opened up about feeling anxious and uneasy when he does not work every day.

In his blog, Mr Bachchan wrote, “You wonder why the day is not behaving the way you normally wish it to be. So, if there is some understanding of this element within us, then ‘may there be peace and calm around us’, but for some, it never happens, and that is an added anxiety. Living in anxiety, they say, is harmful for the mind and body, and leading an anxious day on the weakness of this phenomenon is unnecessary (sic).”

Through his post, the 'Piku' actor revealed that a day spent lazing around seems 'disturbing.' He continued to say that when one does not work every day as per a schedule, the day becomes a 'mystery of deeds', which hints at the importance of structure and how a strong routine can shape one's mental health. But what contributes to the anxiety of not being occupied?

Why do some people feel anxious when not working?

According to experts, many people underestimate the importance of a routine for mental health. Humans are wired to depend on structure for stability, and when that is eliminated, the mind has to reorganise internally. This does not come easily. However, from a psychological perspective, this can lead to an excessive cognitive load, triggering a stress response. This stress response can manifest as anxiety, uneasiness, irritability, or restlessness.

How to cope with the stress on a lazy day?

Experts say that unproductiveness need not be associated with work itself—one can also engage in household chores or a hobby to feel productive and engaged. On a free day with no schedule, creativity can offer an escape. One can try going for a walk, cooking, taking breaks from screens every few minutes, and even playing sports. This helps regulate the nervous system. It can support not just physical but also emotional recovery. This way, when the brain takes a break, it does not feel empty and recovers faster.

How to feel productive on your day off?

When not at work, there are some simple ways to avoid falling into a slump. You can take a break and still be productive, and here are some simple ways to do so:

1. Organise: If you spot clutter in any part of the house, work towards organising it better. This activity is not exhausting and is also a good way to feel productive.
2. Prepare meals: On your day off, prepare yourself a fancy meal. Not only does this engage the creative side of your mind, but it also releases happy hormones.
3. Sightseeing: If you are willing to go out on your day off, pick a spot in the city that you have never visited and go sightseeing. Even getting dressed for a day out can help you feel rejuvenated.
4. Engage in sports: Engaging in sports is a good way to take a break from busy workdays. Go swimming or play a sport such as tennis or badminton, and the activity will help release happy hormones.

India is already known as the 'Pharmacy of the world', supplying 60 percent of the world’s vaccines and 20 percent of generic medicines. The country is soon transforming into a global bio-pharma hub, said the government today.

To achieve this, the focus must be on biosimilars and specialty medicines, said J P Nadda, Union Minister for Health & Family Welfare and Chemicals & Fertilizers.

He said this while making a virtual address at the 9th edition of India Pharma 2026, the flagship event of the Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, today in New Delhi.

Shift Towards Biologics and Biosimilars

Nadda emphasized that India has long been recognized as the “pharmacy of the world” due to its leadership in affordable generic medicines. However, the global landscape is now rapidly shifting towards biologics, biosimilars, and specialty medicines.

“In this evolving environment, India is well positioned not only to adapt but to emerge as a global leader,” he stated.

Nadda reaffirmed the government’s commitment to fostering innovation and boosting research capabilities with schemes such as:

• Biopharma Shakti Initiative, with an outlay of Rs 10,000 crore, aimed at advancing capabilities in biopharmaceutical innovation.
• The PRIP scheme for promoting research in
• pharmaceuticals and medical technology.
• The Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing
• The development of bulk drug parks aims to enhance self-reliance and resilient supply chains.

Rising Global Demand For Biologics And Biosimilars

Further, Minister of State for Health & Family Welfare and Chemicals & Fertilizers, Anupriya Patel highlighted that India is undergoing a significant transition from being a global generics leader to an emerging biopharma innovation hub.

"India currently contributes nearly 20 percent of global generic medicines and meets around 70 percent of global vaccine demand, underscoring the country’s robust manufacturing capabilities,” Patel said.

Emphasizing future opportunities, she stated that the global demand for biologics and biosimilars is expanding rapidly, with the biosimilars market projected to reach USD 75 billion by 2030.

She further pointed out that innovative drugs account for nearly 87 percent of the global pharmaceutical market value, underlining the need for India to intensify its focus on innovation-driven segments.

Patel also outlined the integration of artificial intelligence in drug discovery and development.

She emphasized the importance of strengthening human capital through premier institutions such as NIPERs and IITs to support advanced research and innovation.

The two-day conference was organized in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA).

To transform India into an “innovator for the world”, other government officials stressed the need to:

• accelerate innovation timelines
• strengthen startup ecosystems
• build a robust infrastructure for clinical trials
• advanced research
• enhanced funding mechanisms
• closer industry-government collaboration
• development of skilled talent.